Vorhofflimmern hat als häufigste anhaltende Arrhythmie durch den demografischen Wandel
an Bedeutung gewonnen. Aktuelle Studien belegen, dass die Behandlung von Risikofaktoren
und Komorbiditäten das Fortschreiten der Erkrankung verhindert und die Ergebnisse
einer rhythmuskontrollierenden Therapie verbessert. Dazu empfehlen Leitlinien zum
Vorhofflimmern ein ganzheitliches Behandlungskonzept, welches einen interdisziplinären
Ansatz umfasst.
Abstract
Atrial fibrillation (AF) is the most common sustained arrhythmia and has gained increasing
importance due to demographic changes. The development of AF is multifactorial, including
both non-modifiable risk factors such as age and genetic predisposition, as well as
modifiable factors like obesity and alcohol consumption. Common comorbidities include
arterial hypertension, heart failure, sleep apnea syndrome, and diabetes mellitus.
Current studies show that treatment of these risk factors and comorbidities prevents
the progression of AF and improves the results of rhythm control therapy. Preventive
measures such as weight reduction, physical activity, abstinence and controlling cardiovascular
risk factors are important measures to achieve pre-defined therapy goals. Both the
German and European AF-guidelines advocate for a comprehensive treatment approach,
incorporating an interdisciplinary strategy that fosters collaboration across multiple
specialties to effectively treat risk factors and comorbidities.
Schlüsselwörter
Vorhofflimmern - Risikofaktoren - Komorbiditäten - Adipositas
Keywords
atrial fibrillation - risk factors - risk factor management - comorbidities - obesity
